GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jiang Xi Sanxin Medtec Co Ltd (SZSE:300453) » Definitions » Cyclically Adjusted FCF per Share

Jiang Xinxin Medtec Co (SZSE:300453) Cyclically Adjusted FCF per Share : ¥0.13 (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Jiang Xinxin Medtec Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Jiang Xinxin Medtec Co's adjusted free cash flow per share for the three months ended in Mar. 2025 was ¥-0.015. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.13 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Jiang Xinxin Medtec Co's average Cyclically Adjusted FCF Growth Rate was 30.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2025-06-02), Jiang Xinxin Medtec Co's current stock price is ¥8.19. Jiang Xinxin Medtec Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was ¥0.13. Jiang Xinxin Medtec Co's Cyclically Adjusted Price-to-FCF of today is 63.00.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Jiang Xinxin Medtec Co was 100.00. The lowest was 50.82. And the median was 64.92.


Jiang Xinxin Medtec Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Jiang Xinxin Medtec Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiang Xinxin Medtec Co Cyclically Adjusted FCF per Share Chart

Jiang Xinxin Medtec Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.11 0.12

Jiang Xinxin Medtec Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.11 0.13 0.12 0.13

Competitive Comparison of Jiang Xinxin Medtec Co's Cyclically Adjusted FCF per Share

For the Medical Instruments & Supplies subindustry, Jiang Xinxin Medtec Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiang Xinxin Medtec Co's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Jiang Xinxin Medtec Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Jiang Xinxin Medtec Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Jiang Xinxin Medtec Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jiang Xinxin Medtec Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.015/115.1156*115.1156
=-0.015

Current CPI (Mar. 2025) = 115.1156.

Jiang Xinxin Medtec Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.024 99.500 0.028
201509 -0.001 100.500 -0.001
201512 0.049 100.600 0.056
201603 -0.050 102.200 -0.056
201606 -0.041 101.400 -0.047
201609 -0.044 102.400 -0.049
201612 0.033 102.600 0.037
201703 -0.043 103.200 -0.048
201706 0.000 103.100 0.000
201709 -0.040 104.100 -0.044
201712 0.040 104.500 0.044
201803 -0.037 105.300 -0.040
201806 -0.050 104.900 -0.055
201809 -0.051 106.600 -0.055
201812 -0.001 106.500 -0.001
201903 -0.133 107.700 -0.142
201906 -0.007 107.700 -0.007
201909 0.048 109.800 0.050
201912 0.154 111.200 0.159
202003 -0.007 112.300 -0.007
202006 0.109 110.400 0.114
202009 0.081 111.700 0.083
202012 0.141 111.500 0.146
202103 -0.062 112.662 -0.063
202106 0.054 111.769 0.056
202109 0.150 112.215 0.154
202112 0.155 113.108 0.158
202203 -0.034 114.335 -0.034
202206 0.036 114.558 0.036
202209 0.008 115.339 0.008
202212 0.366 115.116 0.366
202303 -0.177 115.116 -0.177
202306 0.141 114.558 0.142
202309 0.097 115.339 0.097
202312 0.040 114.781 0.040
202403 -0.043 115.227 -0.043
202406 0.092 114.781 0.092
202409 0.272 115.785 0.270
202412 0.010 114.893 0.010
202503 -0.015 115.116 -0.015

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Jiang Xinxin Medtec Co  (SZSE:300453) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Jiang Xinxin Medtec Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=8.19/0.13
=63.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Jiang Xinxin Medtec Co was 100.00. The lowest was 50.82. And the median was 64.92.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Jiang Xinxin Medtec Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Jiang Xinxin Medtec Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiang Xinxin Medtec Co Business Description

Traded in Other Exchanges
N/A
Address
No. 999, Fushan Avenue, Xiaolan Economic Development Zone, Nanchang County, Jiangxi Province, Nanchang, CHN, 330200
Jiang Xi Sanxin Medtec Co Ltd is engaged in researching and developing, manufacturing and marketing of medical devices. Its products include four series: blood purification, indwelling catheters, injections, infusion and blood transfusion. Blood purification products are used in clinical dialysis treatment for uremic patients. Indwelling catheter products represented by venous indwelling needles, positive pressure indwelling needles, central venous catheters. Injectable products mainly include self-destructing syringes, retracting self-destructing syringes, conjoined syringes.
Executives
Zhang Lin Supervisors
Le Zhen Rong Executives
Mao Zhi Ping Directors, executives
Yu Zhen Zhu Supervisors
Peng Yi Xing Director
Liu Ming Securities Affairs Representative
Wan Xiao Ping Director
Wang Qin Hua Supervisors
Xiong Yan Supervisors

Jiang Xinxin Medtec Co Headlines

No Headlines